Vanadate can replace interleukin 3 for transient growth of factor-dependent cells
- 30 June 1987
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 171 (1) , 16-23
- https://doi.org/10.1016/0014-4827(87)90247-3
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines.The Journal of Experimental Medicine, 1986
- Permissive role of interleukin 3 (IL‐3) in proliferation and differentiation of multipotential hemopoietic progenitors in cultureJournal of Cellular Physiology, 1985
- Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteinsCell, 1985
- Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanismCell, 1985
- Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanismCell, 1985
- Effect of haematopoietic cell growth factor on intracellular ATP levelsNature, 1983
- Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadateBiochemical and Biophysical Research Communications, 1982
- Vanadate, epidermal growth factor and the stimulation of DNA synthesisBiochemical and Biophysical Research Communications, 1981
- Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosineNature, 1980
- Vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase and other ATPasesBiochemical and Biophysical Research Communications, 1979